Gene expression deconvolution is a powerful tool for exploring the microenvironment of 17 complex tissues comprised of multiple cell groups using transcriptomic data. Characterizing 18 cell activities for a particular condition has been regarded as a primary mission against diseases.
Introduction 41
Exploring the cellular components of heterogeneous tissues from their gene expression profiles 42
is an essential work for revealing molecular mechanisms across different cell types. For 43 instance, increasing evidence suggests that levels of tumor-infiltrating immune cells are 44 associated with tumor progression, response to therapy, and patient survival (Dieu-Nosjean, et 45 al., 2014 ; Fridman, et al., 2012; Fridman, et al., 2017) . Thus, powerful technologies for single-46
cell isolation, such as laser microdissection and flow cytometry, have been employed to 47 quantify the numbers of malignant and normal cells in tissue (Hu, et al., 2016) . However, these 48 physical approaches to isolating cells of interest at the gene expression level are costly and 49 time-consuming, resulting in drastically reduced biological-content yields. In contrast to 50 single-cell technologies, RNA-seq and microarrays yield bulk gene expression from hundreds 51 of thousands of cells. In heterogeneous tissues, where more than one cell type is present, the 52 expression profile from bulk RNA-seq or microarrays is from cell mixtures; thus, to correctly 53 interpret these data, gene expression deconvolution approaches are required to recover cell 54 type-specific expression and the distinct cellular proportions within complex tissues. 55
In the study of gene expression deconvolution, numerous computational and statistical 56 approaches have been proposed to characterize cell subpopulations within tissues ( Expression data from a heterogeneous tissue can be modeled as a linear combination of the 60 distinct expression profiles of the cells present in that tissue, weighted by the corresponding 61 cell fractions. These approaches can be grouped into one of three categories depending on 62
whether they use a prior database of cell type-specific expression profiles in the deconvolution 63 procedure: reference-free, reference-based, and semi-reference-based methods. Reference-free 64 approaches aim to directly perform expression deconvolution without cell type-specific 65 references, and their most significant feature is that they estimate the relative cellular 66
proportions and simultaneously disentangle their expression profiles. For instance, many 67 studies have been leveraged on non-negative matrix factorization to decompose mixed gene 68 expression matrices into cell fractions and their corresponding expression profiles (Gaujoux 69 and Seoighe, 2012; Prassas, et al., 2012) . Although reference-free models are valuable in the 70 exploration of an uncharacterized cell population, such as tumor subclones (Xie, et al., 2018) , 71
relating the cellular components they identify to specific cell types of interest is difficult. Hence, 72
the results of reference-free approaches are unable to clarify the association between a 73 particular cell type and disease progression. 74
By contrast, reference-based methods incorporate external expression profiles of pure 75 cell samples for deconvolution. For example, the analytical tool CIBERSORT successfully 76
borrows cell type-specific information to predict the immune cell components in blood tissues 77
and tumors through ν-support vector regression (ν − SVR) (Charoentong, et al., 2017; Newman, 78 et al., 2015) . A fundamental assumption about reference-based models is that all types of cells 79 present in the target tissues are included in the reference set, and the cellular proportions should 80 sum up to one. Unfortunately, the pure expression profile of malignant cells, a key component 81 in tumors, is a great challenge because of the high genetic heterogeneity of tumors. Hence, 82
reference-based models can only derive the relative cell proportions concerning the reference 83 set rather than the exact proportions concerning the microenvironment. Therefore, the relative 84 cell proportions are not comparable across samples. To overcome this problem, TIMER adopts 85 a series of deconvolution procedures to adjust the relative cell proportions with tumor purity, 86
which is the content of malignant cells in a tumor (Li, et al., 2016) . 87
The abovementioned limitation forms the main incentive for developing semi-88
reference-based deconvolution approaches. In 2017, Racle et al. proposed a framework for 89 estimating the proportion of immune and cancer cells (EPIC) for RNA-seq data (Racle, et al., 90 2017) . EPIC applies least-squares regression with a non-negativity constraint to the 91 deconvolution problem, and requires that the sum of all cell proportions in each tissue must be 92 less than or equal to one. When the sum is not equal to one, one minus the sum of the estimated 93 cell proportions represents the fraction of uncharacterized cells in a tissue that is not accounted 94
for by the reference set; this number is interpreted as the malignant cell proportion in a bulk 95
tumor. 96
Although semi-reference-based models demonstrate the advantages of incorporating 97 cell-specific information and simultaneously extracting the uncharacterized cell types present 98
in tissues, two problems behind these models should be addressed to complete the framework 99 of gene expression deconvolution. First, signature gene selection is critical to the performance 100 of gene expression deconvolution. In some studies, the incorporation of a preselected signature 101 gene set has successfully improved the accuracy of immune cell deconvolution (Chen, et and is a semi-reference-based approach. Under the Gaussian assumption, we first considered 117 stochastic search variable selection (SSVS) for novel signature gene selection (George and 118
McCulloch, 1993). The SSVS approach has been widely used in transcriptome analyses to 119 select significant genes. For example, Ishwaran and Rao introduced a rescaled Bayesian model 120
for selecting differentially expressed genes through multi-group microarray data (Ishwaran and  121 Rao, 2005). To the best of our knowledge, BayICE is the first attempt to incorporate the 122 mechanism of feature selection for inferring the cellular components of bulk tissues. Moreover, 123
we claim that the BayICE model possesses the shift-invariant property of deconvolution, which 124 yields unbiased estimates of cellular proportions. The model with the shift-invariant property 125 further guarantees that it can recover the expression profiles of uncharacterized cells using 126 posterior mean inference. For the purpose of inference, we applied Gibbs sampling and the 127
Metropolis-Hastings as the sampling procedure in the estimation. In brief, BayICE performs 128 cellular component estimation, uncharacterized cell expression profile estimation, and a novel 129 strategy for signature gene selection. 130
The remainder of this paper is organized as follows. Section 2 introduces the 131 deconvolution in gene expression and states the shift-invariant property. Section 3 introduces 132 the statistical modeling of BayICE for gene expression deconvolution and proposes a Markov 133
chain Monte Carlo (MCMC) algorithm for simulating the posterior distributions of parameters.
134
To assess the model's performance, Section 4 presents simulation studies that investigate gene 135 expression deconvolution, gene selection, and model robustness compared to two existing 136 methods. Section 5 presents applications to two real datasets where underlying true cell 137
proportions are known and performance can be benchmarked. Section 6 describes application 138
of BayICE to 199 non-small cell lung cancer RNA-seq samples and exploration of the cell 139 components present in the microenvironments of lung tumors. Finally, Section 7 provides final 140 discussion and conclusions. where E is the gene expression of gene g, EF is the expression of the k-th cell type in gene g, 146
and D is the distance metric. In general, D is the Euclidean distance. As mentioned above, the 147 reference-free deconvolution approaches assume the cell type-specific expression ( EF ) is 148
unobserved, and the reference-based methods, by contrast, require EF as input for the 149 optimization problem. Additionally, the semi-reference-based approaches allow that one of the 150 cell types is absent in the reference. We now define the shift-invariant property to characterize 151 different deconvolution models. The shift-invariant property in Definition 1 is essential for evaluating the deconvolution 162 methods, especially in the genomic study. Since the protocol of a gene expression experiment 163
is typically designed for each study, the mean read depth varies across experiments. More 164 specifically, the different experimental protocols cause the location parameters of expression 165 distributions to change. If the location parameter affects the estimation of the same composition, 166
then it is not reasonable to compare results across studies. However, the shift-invariant property 167
guarantees that a deconvolution method with this property can estimate the proportions 168 precisely when the location parameter is changed, and thus, the between-study comparison is 169 valid. In the supplementary file, we have shown that the reference-free and reference-based 170 deconvolution approaches follow the shift-invariant property. By contrast, EPIC adopted the 171 inequality-constrained optimization method to derive cell proportions lacks the shift-invariant 172
property, and hence the following simulation result reveals that the estimates of EPIC are 173 biased. 174
To address the issue of shift-invariant property for the semi-reference-based 175 deconvolution approaches, we proposed a Bayesian deconvolution model which is more robust 176
to the change in the location parameter. The Bayesian hierarchy architecture facilitates the 177 construction of equality-constrained objective function for the semi-reference-based 178 deconvolution problem via likelihood approach. The proof details in the supplementary 179 material, and the model construction will be detailed in the next section. 180
BayICE Deconvolution Model

181
In this section, we present the proposed hierarchical Bayesian deconvolution model for 182
intracellular component exploration with novel signature gene selection. Figure 1 provides a 183 graphical representation of the BayICE hierarchical model. We first describe the input data and 184 establish the statistical modeling for reference samples and tumor samples. Subsequently, a 185 stochastic search method, the Bayesian false discovery rate, and an inflation factor are 186
introduced for signature gene selection. Finally, we adopt the Gibbs sampling approach and 187
the Metropolis-Hastings approach to develop a comprehensive sampling procedure. 188
Figure 1. Bayesian hierarchical model of BayICE
The square symbols represent observed data from the reference set and bulk tissues. The white circles indicate priors and the grey circles are hyperparameters. normalization is to make the sum of all TPMs equal across samples, which facilitates fair 199 comparisons between samples. For public data, TPM normalization approach is not always 200 available because the information of sequencing depth or gene length required for TPM could 201 be missing. Thus, we adopt subsampling normalization as the second strategy. Subsampling 202 normalization applies a binomial sampler to resample the read count, and it aims to maintain 203 internal associations between genes and can simultaneously adjust external variance between 204
Input data and normalization
samples. The details of how we implement the two normalization approaches are provided in 205 the supplementary materials. After normalization by the first strategy or the second strategy, 206
we consider a log transformation by log(count + 1). The log transformation of count data has 207 been widely applied in RNA-seq studies. 208
Statistical modeling 209
The problem of gene expression deconvolution can be formulated as a system of linear 210 equations that describes the expression of a given gene in a bulk tissue as the weighted sum of 211
the expression values from multiple cell types present in the tissue. To maximize the 212 deconvolution power, BayICE incorporates a reference set comprising cell-specific expression 213
profiles into the inference of cellular components in bulk tissues. In this study, the reference 214 set contains various types of immune cells, such as T cells, B cells, natural killer cells, 215 monocytes, neutrophils, and normal tissue cells. In addition to these nonmalignant cells, 216 malignant cells are a major cellular component of tissues in cancer deconvolution studies. 217
Unfortunately, the high genetic heterogeneity of malignant cells hinders the possibility of 218
constructing a predefined cancerous cell expression profile that can be applied to every bulk 219 sample. To address this problem, BayICE takes the advantages of the flexibility of hierarchical 220
Bayesian inference to extract malignant cell profiles directly from bulk tissues. Moreover, 221
BayICE infers cellular proportions with respect to the reference cell types and unknown cell 222 types of each tissue by integrating with a Bayesian signature gene selection approach. 223
We first introduce the statistical model for the reference set consisting of N purified 224 samples with K cell types. We denote an observation in this set as ER , which is the normalized 225 value for gene-g (g = 1, …, G) in the i-th purified sample (i = 1, …, N). The N purified samples 226
belong to K nonmalignant cell types that exist in the bulk tissues. We introduce a binary vector 227 variable R. = ( R* , … , R-) to represent the cell type for the i-th purified sample. More 228 specifically, if the i-th purified sample belongs to cell type k, then RF = 1 and RV = 0 for all 229
≠ . BayICE assumes that ER follows the Gaussian distribution with a mean level ER and a 230 gene-specific variance denoted by ],Ê . For the purpose of signature gene identification, we 231
consider the mean structure ER to comprise a gene-specific baseline ( E ) and cell type-specific 232 effects ( EF ). Thus, the modeling of reference data can be written as 233
To search for signature genes that exhibit a differential effect among cell types, we define a 234 baseline cell type against which changes in expression levels are measured. We set E* to be 0 235 for all gene-g. 236
The cell type-specific effects ( E* , … , E-) in (3.1) are shared in constructing the mean 237 structure of gene expression in bulk tissues. It has been observed in the literature that gene the j-th bulk tissue (j = 1, …, M) is denoted by El . The mean of El , called El , can be modeled 244
as the weighted sum of nonmalignant cell-specific effects { EF } and one malignant cell-245 specific effect En through a linear regression, given by 246
The weights, lF , are the proportions of expression attributable to normal cell type k in the j-247 th tumor, and the weight, ln , represents tumor purity, which is the percentage of malignant 248 cells in a tumor tissue. Notably, BayICE can be used to explore not only tumors but also other 249 noncancerous tissues. For noncancerous tissues, ln can refer to the proportion of one 250
unknown cell type that is uncharacterized by the reference set. In our model, a natural constraint 251
for these cell proportions is that the sum of weights across cell types should be one (i.e., 252 ∑ lF -Fj* + ln = 1 for each j). Furthermore, to characterize the gene expression pattern in 253 malignant cells, we introduce a tumor-specific parameter En to represent the effect size of 254 gene-g in cancer. In a real application, multiple unknown cell types or cancerous cell types 255 might be present in a bulk tissue. In this case, BayICE treats these uncharacterized cell types 256
as a whole, and ln represents the proportion of unknown class in a bulk tissue. 257
Novel gene selection using the SSVS approach 258
Identifying signature genes that are expressed in a particular cell type is essential to the success 259 of expression deconvolution. Although a preselected signature gene set could be easily applied 260
to data analysis, the application of external signature genes could lose data-dependent 261 information for deconvolution. Thus, we incorporate the stochastic search variable selection 262
(SSVS) approach into our Bayesian deconvolution model for integrating expression 263 deconvolution with novel signature gene selection. The SSVS approach, introduced by George 264
and McCulloch (1993), specifies a spike-and-slab mixture prior, which uses data to extract the 265 potential features of the true model by inferring posterior probability. The spike component, 266
which concentrates its mass at values close to zero, shrinks small effects to zero, whereas the 267 slab component spreads its mass over a wide range of possible values for the effect size. 268
The proposed prior structure of BayICE on effect size exhibits a bimodal distribution 269 on the variance of the coefficients that result in a spike-and-slab type prior on the effects 270 themselves (Ishwaran, et al., 2010; . For each effect size EF , the prior 271 structure is given by 272
where u o EF f is a mass function that is 1 at EF =c and 0 everywhere else. We set the value c 273
as a small positive number in this study, such as c = 10 }~, and thus the random variable EF is 274 1 with probability F and close to zero with probability 1 − F . When the g-th gene is 275 differentially expressed between the k-th cell type and the other types, EF is more likely 276 generated from the slab component and EF equals one. By contrast, EF = indicates that the 277 g-th gene is irrelevant to cell types and its effect size is from the spike component. The 278
hypervariance EF is sampled from an inverse gamma with two given hyperparameters, n and 279 n . Following , n and n are set as 5 and 50, respectively. The 280
proportion of genes differentially expressed in cell type k is controlled by F , and we assume 281 that F follows a beta distribution with n = 0.1 and n = 0.1. 282
To borrow variance information across samples, we modify the variance structure of 283 effect size EF in (3.3) by considering the gene-specific variance p,Ê of mixture samples in 284
(3.2) and the modified prior structure for EF is given by 285
The role of the gene-specific variance p,Ê that appears in (3.4) can be intuitively interpreted 286
as the baseline in the feature selection procedure. The modified prior structure considers the 287 trade-off between the value of effect size and gene-specific variance to facilitate the 288 establishment of feature selection. 289
Bayesian false discovery rate 290
In frequentist approaches to the test multiplicity problem, controlling the false discovery rate 291
(FDR) has been widely applied to more adequately control genome-wide false positives. 292
Whittemore in 2007 introduced a Bayesian FDR associated analogously with the frequentist 293 FDR (Whittemore, 2007) as follows: 294
(3.5)
where EF ( n | , ) is the posterior probability that gene-g is not associated with cell type k 295 (H0) given observation (Y, Z), and EF ( ) is the rejection rule defined by I( EF ( n | , ) < ).
296
The tuning parameter r can be adjusted to control the Bayesian FDR at a certain α level. In the 297 following simulations and applications, the Bayesian FDR is used to address the multiplicity 298 problem. 299
Inflation factor 300
In a Bayesian framework, the influence of priors on posterior always vanishes as the 301 sample size increases. This phenomenon limits Bayesian variable selection because the 302 mechanism of such selection requires an effective prior setting. To overcome this disadvantage, 303
Ishwaran and Rao (2005) proposed a rescaling approach to enable estimation invariant to the 304 sample size by setting the prior as a function of the sample size. They applied data rescaling to 305 the gene selection framework for multi-group microarray data. Furthermore, to achieve 306 invariance to sample size, Ishwaran and Rao performed a sample size-related transformation 307 of gene expression through multiplication by the global inflation factor 308 †(total sample size)/ (estimate of total variance). 309
Multiplication by this global inflation factor has been shown to ensure that the prior has a 310 nonvanishing effect. Hence, following the concept of data transformation, we rescale the 311 observations in our reference set and bulk tissue set as follows: 312 reference set. Although we assume that the variance Ê of reference data { ER } is shared with 314 tissue data { El }, the calculation of an unbiased estimator using both { ER } and { El } data is a 315 difficult task because of the convolution structure in { El }. Note that the multiplier in (3.6) is 316 a gene-specific inflation factor rather than the abovementioned global inflation factor since the 317 inflation factor is composed of the total sample size and a gene-related variance. Therefore, the 318 use of gene-specific factors can simultaneously achieve sample size invariance and gene-scale 319 consistency. 320
After rescaling, the corresponding distributions for the transformed data { ER * } and 321
{ El * } are modified as follows: 322
The new variances of the transformed data are adjusted as sample size-related parameters, and 323
this adjustment can be interpreted as a penalization shrinkage effect of the posterior mean. 324
After the adjustment with inflation factors, the variances of ER * and El * are asymptotically 325 equal to N+M. For the purpose of variable selection, we introduce two further parameters Ê 326
and Ê for variances in (3.7) to keep the flexibility of modeling. 
where hyperparameters are specified as n = 5, n = 50, n = 1, n = 1, and = 1 in this 333 study. 334
Subsequently, based on the hierarchical prior setting, we apply Gibbs sampling and the 335
Metropolis-Hastings approach to simulate the posterior value from 336 in the supplementary file. After a number of iterations, we specify the burn-in period and the 340 thinning interval to obtain the posterior distribution of the parameters and then perform an 341 analysis using the posterior mean or posterior median. In BayICE, the default length of burn-342 in is 0.6 times the number of iterations, and the thinning interval has a length of 3 iterations. 343
The convergence property is discussed in the supplementary materials. 344
Simulation Study
345
This section presents simulation results based on synthetic datasets to benchmark the 346 performance of BayICE. We consider two types of data: array-based data, which is generated 347 by a normal simulator, and sequencing-based data, which can be produced by a multinomial 348 simulator or negative binomial simulator. We mainly use the multinomial simulator to 349 demonstrate the estimation of cellular proportions, detection of signature genes, and the ability 350
to recover the expression profile of unknown or malignant cells. Furthermore, we apply three 351 different simulators to demonstrate the robustness of BayICE, and the results of the robustness 352 study are shown in the supplementary file. 353
Multinomial simulator settings 354
We first perform a sequencing-based simulation using a multinomial simulator for expression 355 deconvolution. Thus, we consider a scenario in which five distinct cell subpopulations are 356 present in a tissue, and one cell type is absent from our reference set. This simulation includes 357 5000 genes, with 300 genes designed as cell type-related genes. These 300 genes are divided 358 randomly into five disjoint groups, and the genes assigned to a particular group are associated 359 with one cell type. For each cell type in a reference set, we have 20 replicates; hence, the 360 reference set includes 80 samples. In the reference set, an 80 × 4 matrix of binary variables 361 X = { RF } is used to record the cell type of samples. Furthermore, in the bulk dataset, we 362 simulate the expression data of 90 mixed samples with different cell proportions. The 363 simulation procedure is described as follows. 364
To account for the fact that the expression level varies across genes, we simulated data 365
according to a set of real data from purified samples. We collected 19 RNA-seq samples of 366 normal lung tissues from the Gene Expression Omnibus database with accession number 367 GSE81089 (Mezheyeuski, et al., 2018) , and then took the average gene expression across 19 368
samples to obtain the baseline E ÀRÁ of the g-th gene. Among 17,775 genes, we randomly 369 picked 5000 genes for our simulation study. Based on each gene-specific expression level, we 370 define the cell-specific effect as follows: 371
where E ÀRÁ is a binary variable, which is 1 for upregulated status and 0 for downregulated 373 status, and NES is the normalized effect size set as one of the numbers {0.1, 0.2, … , 0.6}. The 374
number { E ÀRÁ } is randomly generated with a probability of 0.5 for 0 and 1. We further sample 375 a series of values from Uniform(0.9,1.1), called { R ÀRÁ }, as sample-specific effects because of 376 the sample heterogeneity. Finally, we generate cellular proportions { l* ÀRÁ , … , l-ÀRÁ , ln ÀRÁ }. To 377 explore the effect of unknown cell content on the model performance, we assign a fixed number 378 to ln ÀRÁ , and the remaining components { l* ÀRÁ , … , l-ÀRÁ } are generated from the Dirichlet 379 distribution with parameters (1,…,1). Because of the sum-to-one constraint on cellular 380
proportions, b l* ÀRÁ , … , l-ÀRÁ , ln ÀRÁ c should be normalized by dividing their sum. 381
The mean expression structure is determined for both purified and mixed samples 382
according to the abovementioned parameter settings. Notably, the use of a multinomial model 383 in our simulation is to simulate the sequence alignment procedure that maps the reads against 384
the reference sequence. The number of trials in the multinomial model is related to the total 385 reads, and we set it as 5 × 10 Ê ; in other words, the average read depth is designed as 1000. The 386
probability of the multinomial model controls the expression levels across genes, and therefore, 387
we use the relative mean expression as the probability value. The complete sampling procedure 388 details in the supplementary file. 389
Assessing the inference of deconvolution 390
To assess the performance of BayICE deconvolution, we include two semi-reference-based 391 approaches for comparison: EPIC and non-negative least-squares (NNLS). NNLS is a general 392 approach for solving the constrained least-squares problem where the coefficients are not 393 allowed to become negative. We modify the NNLS approach by restricting the sum of 394 coefficients to less than one for incomplete reference data deconvolution. We first examine the 395 cellular proportion estimations obtained using EPIC, NNLS, and BayICE. Notably, EPIC and 396
NNLS both require an external step to identify signature genes before deconvolution. We first evaluate the estimation of gene expression profiles for the unknown cell type 410
and gene identification from BayICE in Figure 2 . Figure 2(A) is a scatter plot between the true 411 expression of the unknown cell type and the estimated expression. The results reveal the 412 correlation between the real and estimated values to be greater than 0.98, which implies that 413
BayICE can recover uncharacterized cell expression when one cell type is absent from the 414 reference set. In Figure 2(B) , we adopt the receiver operating characteristic (ROC) curve to 415 quantify the results of gene identification under different normalized effect sizes which 416
represent the strength of cell type-specific activity in marker genes. The performance in terms 417
of area under the curve (AUC) is significantly improved with the increase of the effect size, 418
and more specifically, the AUC exceeds 0.94 when the effect is larger than 0.2. Subsequently, 419
we apply root-mean-square error (RMSE) to quantify the accuracy of cell proportion estimation 420
from BayICE, EPIC, and NNLS. Figure 3 
(A) illustrates the changes in RMSE of all estimates 421
with the increase of normalized effect size under the settings of unknown cell proportion = 0.1, 422 0.5, and 0.9. In Figure 3(B) , we fix the normalized effect size at 0.1, 0.3, and 0.6 and then 423 evaluate those approaches across different proportions of unknown cells. As a result, it is clear 424
that the performance of all approaches decreases when the unknown cell content increases or 425
the effect size decreases. The abovementioned phenomenon reflects that these gene expression 426
deconvolution approaches are less stable in their inference for tissues with highly 427
uncharacterized content or weak cell type-specific signal. However, the simulation shows that 428 the effects of high unknown cell content and low effect size on BayICE estimation are less 429 severe, and overall, BayICE outperforms the other methods. 430 Root-mean-square error (RMSE) between the true and estimated cellular proportions under (A) different effect sizes or (B) different proportions of unknown cells. Ten random sets were generated for each condition, and the RMSE in a set was calculated with five pairs of numbers. The medians of the 10 random sets were connected as the line in the figure.
Evaluating gene detection accuracy 432
The spike-and-slab prior in our model provides a natural consequence of gene selection. In 433 contrast, the existing models require an external tool to select differentially expressed genes 434 before deconvolution, and DESeq and edgeR are two popular gene selection tools adopted by 435 the deconvolution models. To evaluate the accuracy of gene detection, we compare with 436
DESeq and edgeR. It is worth noted that the genes specifically expressed in the unknown cell 437 type cannot be identified using DESeq and edgeR, and hence the unknown cell type-related 438 genes are excluded in the evaluation. According to the simulation setting, each gene set is 439 differentially expressed in one cell type. For simplicity, the effect size of marker genes is fixed 440 at 0.2, and the cell proportions are randomly decided across samples. In this simulation study, 441
we also assume some genes express inconsistently between purified cells and the same cell 442 type in bulk samples. For each cell type, we randomly select 100 genes from the gene pool to 443 be inconsistent genes, and disturbed the expression of these inconsistent genes by multiplying 444
an inconsistency level. The values of inconsistency level are 0.1, 0.2, 0.3, 0.4, and 0.5, and the 445 mean of the disturbed gene expression is the original mean in Section 4.1 multiplied by 0.9, 446 0.8, 0.7, 0.6, or 0.5. 447
In this partial comparison, we evaluate the accuracy of identifying genes related to the 448 four cell types present in the reference. AUC is used to assess the gene detection under different 449 levels of inconsistency, and the results are shown in Figure 4 . For the low inconsistency level, 450
the AUCs among three methods are close, and it implies that BayICE is comparable to the 451 other approaches designed explicitly for gene selection. In the case of the considerable 452 inconsistency in gene expression, the AUC of BayICE outperforms DESeqs2 and edgeR, and 453
it shows that BayICE succeeds in borrowing information from mixed bulk samples for gene 454
detection. Consequently, this partial comparison reveals that BayICE can efficiently recover 455 the findings of the two-step approaches when cell activity causes the difference in gene 456 expression between pure cells and tumors. 457 Comparison of the AUC performance on gene identification. Measuring the performances of BayIC, DESeq2, and edgeR at identifying marker genes as measured by the Area Under the ROC Curve (AUC).
Validation in real data with true proportions 458
In this section, we consider two microarray mixture experiments for validation. They can be 459 downloaded from the Gene Expression Omnibus database using the accession numbers 460
GSE19830 and GSE11058 (Abbas, et al., 2009 ; Shen-Orr, et al., 2010). The samples from 461 GSE19830 were mixed with rat brain, liver, and lung tissue derived from the same animal in 462 different proportions. The samples in GSE11058 were mixed with four immune cell lines, 463
Jurkat, IM-9, Raji, and THP-1 at various proportions. To validate the performance in the case 464 of the incomplete reference set, we masked one cell type from the reference set and treated the 465 excluded type as the unknown cell component in tissues. Although EPIC is designed for RNA-466 seq data, the core concept of EPIC modeling is constrained least-squares optimization, and it 467
can be widely applied to various types of data. Hence, we also performed comparisons with 468 EPIC and NNLS on the abovementioned two real datasets. 469
Several microarray studies have confirmed that deconvolution on raw-scale data rather 470 than on log-scale data can accurately reflect the underlying cellular components. The raw scale 471 of the data was adopted in this validation study. The signature gene selection for the methods 472
we compared in the microarray followed Hunt et al. (Hunt, et al., 2018) , using a t-test between 473
one cell type and all other cell types for each gene, and we selected the top 200 differentially 474 expressed genes associated with each cell type. 475 Furthermore, the difficulty of deconvolution increases when the abundance of the unknown 491 cell increases. For instance, in Figure 6 , the content of liver cells exceeds 50% of the mixed 492 samples on average, and the deconvolution approaches perform relatively worse when liver 493 cells are excluded from the reference set. The aforementioned observation is consistent with 494 our simulation results. 495 Scatter plots comparing estimated cell proportions between the true and estimated proportions from the results of GSE11058. Each column represents a particular method of deconvolution. The row name indicates the cell type that was masked from the reference set and referred to as the unknown cell type. Each of the 12 mixed sample results in four estimates of weights and thus 4 points in each plot. The root-mean-square error and correlation between the ground truth and estimation are also provided in the upper-left corner of each plot. Scatter plots comparing the true and estimated proportions from the results of GSE19830. Each column represents a particular method of deconvolution. The row name indicates the cell type that was masked from the reference set and referred to as the unknown cell type. Each of the 9 mixed sample results in three estimates of weights and thus three points in each plot. The root-mean-square error and correlation between the ground truth and estimation are also provided in the upper-left corner of each plot.
Application to Non-Small Cell Lung Cancer
497
To demonstrate an application of BayICE to a biological problem, we consider RNA-seq data 498 of lung tissues from patients with non-small cell lung cancer (NSCLC). Because tumor-499
infiltrating lymphocytes play a critical role in cancer treatment, exploring the changes in 500 components of immune cells across tumors is of interest. Thus, we consider 199 patients with 501
NSCLC obtained from GSE81089, and apply BayICE to estimate the cellular components of 502 the tumor-infiltrating lymphocytes in each tumor sample (Mezheyeuski, et al., 2018) . To 503 construct the reference set, we collect RNA-seq samples of B cells, T cells, granulocytes, and 504
monocytes of blood tissues from GSE51984 (Pabst, et al., 2016) . In addition to immune cell 505 types, we include normal lung tissues in the reference set, and the expression profiles of 19 506 normal lung tissues from GSE81089 are used to infer the contents of normal lung cells in 507
tumors. Because the immune cells are also present in normal lung tissues, we first apply 508
BayICE to normal lung samples to extract the purified gene expression of lung cells and 509 estimate the immune cell components in normal samples. Additionally, we randomly divided 510 19 normal samples into two sets: ten samples are used for extracting purified expression of 511 lung cells in Section 6.1, and nine samples are analyzed along with tumors for validation in 512 Section 6.2. As a result, we used the complete reference set consisting of immune cell profiles 513
and purified lung cell profiles to recover the cellular proportions of each NSCLC sample. 514 reveal that monocytes are more prevalent than the other immune cells in lung tissues. 518
Deconvolution of normal lung tissues
Monocytes typically circulate through the blood for 1-3 days before migrating into tissues, 519
where they become macrophages or dendritic cells. In lungs, monocytes migrate from the 520 
Prediction
Ground Truth
Cell Type liver brain lung bloodstream into the pulmonary alveolus and are specifically called alveolar macrophages, 521
which play a critical role in homeostasis, host defense, response to foreign substances, and 522 tissue remodeling (Kopf, et al., 2015) . 523
In addition to the immune cell types collected in the reference set, BayICE could extract 524 the component of one uncharacterized cell type present in tissues. In this case, the unknown 525 cell type was presumably dominated by normal lung cells, and we calculated the mean 526 expression profile of the unknown cell type using the posterior mean. The next step was to 527
integrate the immune cell profiles with the estimated profile of normal lung cells to construct 528 a new reference set for tumor sample deconvolution. 529 
Deconvolution of tumors 530
In this step, we investigated the 199 NSCLC samples and nine healthy samples according to 531
the new reference set. We applied BayICE to these 208 samples and estimated the fractions of 532 normal lung cells, B cells, T cells, granulocytes, and monocytes, as well as malignant cells. 533
Following the mechanism of normal tissue deconvolution, the malignant cell fractions were 534
defined as the unknown cell proportions in tumor deconvolution. To more effectively 535
understand the change in cellular components during tumor progression, we considered the 536 classification of a malignant tumor (TNM) staging system, which is a standard for classifying 537 the extent of cancer spread. Figure 8 (derived from monocytes), which coincides with our observation of estimated monocyte 556
proportions. 557 Orange boxes refer to the results of the nine normal lung samples, and other boxes are results from 199 patients with nonsmall cell lung cancer. The tumor samples can be grouped into six stages and the sample number included for each stage is indicated in the parentheses. For samples of the same tumor stage, the estimated proportions of any specific cell type are summarized as one boxplot and the boxplots for the same cell type are plotted side-by-side.
Discussion and Conclusion
558
In this study, we developed a novel deconvolution model, BayICE, to infer the cellular 559 components of bulk tissues. BayICE is a semi-reference-based approach that aims to explore 560 cell populations characterized by an external reference set of purified samples and 561 simultaneously investigate the content of uncharacterized cells present in bulk tissues. 562
However, in contrast to constrained models, BayICE takes advantage of a hierarchical 563
Bayesian framework to not only estimate the unknown cell proportion but also recover its gene 564 expression profile. Furthermore, BayICE maintains the shift-invariant property, which 565
guarantees the accuracy of cell proportion estimation. 566
Other than the above-mentioned merits, there are two major contributions of this study. 567
First, BayICE integrates gene expression deconvolution and gene selection in the same model. 568
Most of the current deconvolution approaches require pre-analysis of an additional dataset to 569 identify signature genes for deconvolution, and the external gene selection might not be 570 consistent to the target dataset. Thus, BayICE incorporates SSVS, a Bayesian variable selection 571 approach, to implement internal gene selection. Second, BayICE adopts shared parameters 572 between the pure cells and tumor samples for cell-specific effect. It has been studied that the 573 cell-to-environment interaction causes some of the genes to be expressed inconsistently after 574 cell sorting. We have shown that the joint modeling of both pure cells and tumors in BayICE 575
is more resistant to the problem of inconsistent genes. 576 To evaluate the model's performance, we first conducted an analysis under several 577 simulation scenarios to investigate cell proportion estimation, gene identification, and the 578 robustness of the model. For proportion estimation, we compared two other semi-reference-579 based approaches, EPIC and NNLS, with BayICE under different unknown cell contents. The 580 results revealed that BayICE significantly outperformed the other methods. We further 581 provided a partial comparison of gene identification with the well-known gene selection 582 approaches, DESeq and edgeR. We found that BayICE can decompose bulk data extremely 583 well and identify cell type-related genes. Moreover, a simulation study using three different 584 simulators revealed that BayICE is more robust with respect to data types. In addition to 585 simulation data, we further applied two real datasets with underlying true cell proportions for 586
validation. The validation of incomplete data deconvolution was consistent with our simulation 587 results, in which BayICE exhibited high accuracy in cell proportion estimation. 588
Our real data application presented an example using the data of 199 patients with 589
NSCLC. We first applied BayICE to healthy lung samples to investigate the cellular 590 components under a normal condition and extract the relatively purified expression profile of 591 lung cells. The deconvolution of normal tissues succeeded in capturing the primary component 592 of immune cells. Next, we formed a new reference set consisting of the immune cell profiles 593
and estimated normal lung cell profiles to analyze the patients with NSCLC. From the analysis, 594
we observed inter-tumor heterogeneity in NSCLC according to the high variation in cell 595
proportions across tumors. In addition, when comparing immune cell proportions between 596 normal and NSCLC samples, the increased immune cell content in tumors revealed that the 597 immune system was highly activated in the cancerous microenvironment. The inference of 598 NSCLC deconvolution coincides with not only the analytic deconvolution results from other 599 studies but also the observations from an immunohistochemical experiment. 600
